Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2025-12-25 @ 8:24 PM
Study NCT ID:
NCT06241469
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-02-05
First Post:
2024-01-28
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Sintilimab Combined With Nab-paclitaxel and Tegio (aTS) as First-line Treatment of Unresectable Locally Advanced, Recurrent or Metastatic Adenocarcinoma of Gastric and Gastroesophageal Junction，a Phase II Clinical Study
Sponsor:
Wu Jun
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-02-03
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-08-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-02-02
Completion Date Type:
ESTIMATED
First Submit Date:
2024-01-28
First Submit QC Date:
None
Study First Post Date:
2024-02-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-28
Last Update Post Date:
2024-02-05
Last Update Post Date Type:
ACTUAL